These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34004526)

  • 1. Resurgence of COVID-19 and diabetes in India.
    Pal R; Bhadada SK; Misra A
    Diabetes Metab Syndr; 2021; 15(3):1037-1038. PubMed ID: 34004526
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
    Dai W; Wu J; Li T; Shen J; Pang R; Luo T; Guo Y; Yang Y; Zhao J; Zhang M; Li N; Han Y; Wu Q; Li W; Xia X
    J Med Virol; 2021 Apr; 93(4):2321-2331. PubMed ID: 33289151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic emergencies during the COVID-19 pandemic: A case-control study.
    Huda MSB; Shaho S; Trivedi B; Fraterrigo G; Chandrarajan L; Zolfaghari P; Dovey TM; Garrett CG; Chowdhury TA
    Diabet Med; 2021 Jan; 38(1):e14416. PubMed ID: 33025636
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of COVID 19 Second Wave on Children with type 1 Diabetes Mellitus in India.
    Verma A; Verma S; Dochania K; Vaswani ND
    Diabetes Metab Syndr; 2021; 15(4):102171. PubMed ID: 34186360
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.
    Bud ES; Vlasa A; Bud A
    Arch Med Res; 2021 Apr; 52(3):356. PubMed ID: 33220933
    [No Abstract]   [Full Text] [Related]  

  • 9. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
    Gandra S; Ram S; Levitz SM
    Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A post COVID-19 'Marshall Plan' for type 2 diabetes.
    Petrie JR; Boyle JG; Ali K; Smith C; Morrison D; Kar P
    Diabet Med; 2021 Jan; 38(1):e14439. PubMed ID: 33107107
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and Opioid Overdoses: A Pandemic Leads to the Resurgence of an Epidemic.
    Baird C
    J Addict Nurs; 2021 Apr-Jun 01; 32(2):165-166. PubMed ID: 34060769
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the COVID-19 pandemic on delivery of emergency surgical care in India.
    ; Bhandoria G; Gadgil A; Khajanchi M; Sarang B; Kizhakke Veetil D; Wadhawan R; Bhandarkar P; Mohan M; Shah P; Bains L; Mishra A; Arora S; Rattan A; Kant R; Sharma N; Bhavishi D; Satoskar RR; Prajapati R; Srivastava KS; Kamble P; Mayadeo NM; Gokhale A; Jaydeep H; Belekar D; Roy N
    Br J Surg; 2021 Apr; 108(4):e154-e155. PubMed ID: 33793717
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-morbid conditions in COVID-19 patients in Uttarakhand state of India.
    Goel D; Kumar S
    J Glob Health; 2021 Feb; 11():03029. PubMed ID: 33692884
    [No Abstract]   [Full Text] [Related]  

  • 14. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.
    Aljehani FA; Funke K; Hermayer KL
    Am J Med Sci; 2020 Oct; 360(4):423-426. PubMed ID: 32736827
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
    Sartore G; Ragazzi E; Faccin L; Lapolla A
    Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurgence of Urgent-Start Peritoneal Dialysis in COVID-19 and Its Application to Advanced Heart Failure.
    Nassiri AA; Ronco C; Kazory A
    Cardiorenal Med; 2021; 11(1):1-4. PubMed ID: 33412554
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences between First wave and Second wave of COVID-19 in India.
    Jain VK; Iyengar KP; Vaishya R
    Diabetes Metab Syndr; 2021; 15(3):1047-1048. PubMed ID: 33992554
    [No Abstract]   [Full Text] [Related]  

  • 20. Tracking SARS-CoV-2 infection in India with serology.
    John J; Kang G
    Lancet Glob Health; 2021 Mar; 9(3):e219-e220. PubMed ID: 33515513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.